PTC Therapeutics, Inc. (PTCT)
68.81
-0.98
(-1.40%)
USD |
NASDAQ |
May 22, 16:00
68.78
-0.03
(-0.04%)
After-Hours: 20:00
PTC Therapeutics EPS Diluted (Quarterly) : -0.034 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 2.878 |
| Keros Therapeutics, Inc. | -1.208 |
| Insmed, Inc. | -0.7591 |
| Madrigal Pharmaceuticals, Inc. | -3.251 |
| Protagonist Therapeutics, Inc. | 0.0537 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.809M |
| Revenue (Quarterly) | 272.55M |
| Total Expenses (Quarterly) | 275.36M |
| Enterprise Value | 4.210B |
| Gross Profit Margin (Quarterly) | 85.47% |
| Profit Margin (Quarterly) | -1.03% |
| Earnings Yield | -3.40% |
| Normalized Earnings Yield | -3.514 |